Vascular filter having articulation region and methods of use in the ascending aorta

Abstract
Apparatus and methods are provided for use in filtering emboli from a vessel such as the ascending aorta, wherein a vascular device comprises a support hoop having an articulation region connected near a distal end of an elongated member, a blood permeable sac affixed to the support hoop so that the support hoop forms a mouth of the blood permeable sac, a guide wire, and a delivery sheath. The articulation region comprises a reduced thickness region of the support hoop that prevents kinks from forming in the support hoop when the apparatus is contracted to its delivery state, and curved regions that close the mouth of the sac to prevent material escaping from the sac when the apparatus is collapsed for removal.
Description




FIELD OF THE INVENTION




The present invention relates to apparatus and methods for filtering or removing matter from within the vascular system. More particularly, the present invention provides a low profile self-expanding vascular device useful in the ascending aorta for capturing emboli generated during interventional procedures.




BACKGROUND OF THE INVENTION




Percutaneous interventional procedures to treat occlusive vascular disease, such as angioplasty, atherectomy and stenting, often dislodge material from the vessel walls. This dislodged material, known as emboli, enters the bloodstream, and may be large enough to occlude smaller downstream vessels, potentially blocking blood flow to tissue. The resulting ischemia poses a serious threat to the health or life of a patient if the blockage occurs in critical tissue, such as the heart, lungs, or brain.




The deployment of stents and stent-grafts to treat vascular disease, such as aneurysms, also involves the introduction of foreign objects into the bloodstream and may result in the formation of clots or release of emboli. Such particulate matter, if released into the bloodstream, also may cause infarction or stroke.




Numerous previously known methods and apparatus have been proposed to reduce the risk of embolism. U.S. Pat. No. 5,833,644 to Zadno-Azizi et al., for example, describes the use of balloon-tipped catheter to temporarily occlude flow through a vessel from which a stenosis is to be removed. Stenotic material removed during a treatment procedure is evacuated from the vessel before the flow of blood is restored. A drawback of such previously known systems, however, is that occlusion of antegrade flow through the vessel may result in damage to the tissue normally fed by the blocked vessel.




U.S. Pat. No. 5,814,064 to Daniel et al. describes an emboli filter system having a radially expandable mesh filter disposed on the distal end of a guide wire. The filter is deployed distal to a region of stenosis, and any interventional devices, such as angioplasty balloons or stent delivery systems, are advanced along the guide wire. The filter is designed to capture emboli generated during treatment of the stenosis while permitting blood to flow through the filter. Similar filter systems are described in U.S. Pat. No. 4,723,549 to Wholey et al., and U.S. Pat. No. 5,827,324 to Cassell et al.




One disadvantage of radially expandable filter systems such as described in the foregoing patents is the relative complexity of the devices, which typically comprise numerous parts. Connecting more than a minimal number of such parts to a guide wire generally reduces the ability of the guide wire to negotiate tortuous anatomy and increases the profile of the device in its delivery configuration. Moreover, such filter devices are generally incapable of preventing material from escaping from the filter during the process of collapsing the filter for removal.




International Publication No. WO 98/39053 describes a filter system comprising an elongated member, a radially expandable hoop and a cone-shaped basket. The hoop is affixed to the elongated member, and the cone-shaped basket is attached to the hoop and the elongated member so that the hoop forms the mouth of the basket. The filter system includes a specially configured delivery catheter that retains the mouth of the basket in a radially retracted position during delivery.




While the filter system described in the foregoing International Publication reduces the number of components used to deploy the cone-shaped basket, compared to the radial strut-type filter elements described hereinabove, it too has drawbacks. Chief among these, it is expected that it will be difficult to reduce the diameter of the radially expandable hoop to its retracted position. In particular, as the hoop is contracted through smaller radii of curvature, the stiffness of the hoop is expected to increase dramatically. This increased stiffness prevents the hoop from being contracted more tightly and is expected to result in a large delivery profile.




In view of the foregoing disadvantages of previously known apparatus and methods, it would be desirable to provide a vascular device, e.g., for use as a vascular filter in the ascending aorta, that, overcomes such disadvantages, and employs few components.




It also would be desirable to provide a vascular device that is capable of being contracted to a small delivery profile.




It further would be desirable to provide a vascular device that is capable of being advanced into position from the downstream direction of blood flow.




It still further would be desirable to provide a vascular device that reduces the risk of emboli or thrombus removed from the vessel wall escaping from the device when the device is collapsed and removed.




SUMMARY OF THE INVENTION




In view of the foregoing, it is an object of the present invention to provide a vascular device, e.g., for use as a vascular filter in the ascending aorta, that overcomes disadvantages associated with previous vascular filters and thrombectomy/embolectomy devices, and employs few components.




It is another object of the present invention to provide a vascular device that is capable of being contracted to a small delivery profile.




It is yet another object of the present invention to provide a vascular device that is capable of being advanced into position from the downstream direction of blood flow.




It is a further object of this invention to provide a vascular device that reduces the risk of emboli or thrombus removed from the vessel wall escaping from the device when the device is collapsed and removed.




These and other objects of the present invention are accomplished by providing a vascular device suitable for use as a vascular filter in the ascending aorta that comprises a blood permeable sac affixed at its perimeter to a support hoop having an articulation region. The support hoop is attached in a distal region of an elongated member, such as a guide wire, and supports a distally-oriented mouth of the sac when the device is deployed in a vessel. In accordance with the principles of the present invention, the support hoop includes a reduced-thickness articulation region that enables the support hoop to be contracted to very small radii of curvature without the problems of increased stiffness and kinking of previously known devices. The vascular device may therefore be used with delivery sheaths having diameters as small as 3 Fr.




The support hoop preferably also has a curved profile that prevents the articulation region, when folded, from damaging the wall of the vessel. The curved profile also permits the device to effectively contact the walls of the vessel and reduce emboli or thrombus removed from the vessel wall from bypassing the sac. The articulation region, when combined with a support hoop having a curved profile, causes the sides of the support hoop to fold inwards towards one-another when the vascular device is collapsed into a sheath for removal. This, in turn, closes the mouth of the sac and reduces the potential for emboli or thrombus to be released from the vascular device during removal.




Methods of using the vascular device of the present invention are also provided, particularly in the context of a vascular filter placed in the ascending aorta.











BRIEF DESCRIPTION OF THE DRAWINGS




The above and other objects and advantages of the present invention will be apparent upon consideration of the following detailed description, taken in conjunction with the accompanying drawings, in which like reference characters refer to like parts throughout, and in which:





FIGS. 1A and 1B

are, respectively, a side sectional side of a previously known vascular device contracted within a delivery sheath and an end view of that vascular device deployed in a vessel;





FIGS. 2A and 2B

are, respectively, a perspective view of a vascular device constructed in accordance with the principles of the present invention in a deployed state, and a detailed view of the articulation region of the device of

FIG. 2A

;





FIG. 3

is a perspective view of the vascular device of the present invention in a folded configuration, prior to removal;





FIG. 4

is a plan view of the vascular device of

FIG. 2A

;





FIGS. 5A and 5B

are, respectively, side sectional views of an embodiment of the vascular device of the present invention in the contracted state and in the deployed state that is suited for use as a vascular filter in the ascending aorta; and





FIGS. 6A-6C

are side sectional views depicting a method of deploying, using and retrieving the vascular device of

FIGS. 5

in the ascending aorta;











DETAILED DESCRIPTION OF THE INVENTION




Referring to

FIGS. 1A and 1B

, some of the disadvantages associated with previously known vascular devices, such as the emboli filters described in the above-mentioned International Publication WO 98/39053, are described. Vascular filter comprises guide wire


10


having hoop


12


coupled to its end. Filter sac


14


is affixed to hoop


12


, so that when delivery catheter


16


is retracted proximally and guide wire


10


is held stationary, hoop


12


radially expands to contact the walls of a vessel.




As described hereinabove, one difficulty with such vascular filters is that the hoop used to support the filter sac experiences increased stiffness when contracted to small diameters, i.e., due to the sharp directional change at the tip of the hoop, thereby limiting the minimum delivery profile achievable for such instruments. Although this effect may be reduced by decreasing the thickness of the wire employed in hoop


12


, at the point at which the wire becomes sufficiently thin to accommodate the bending stresses, the wire is too thin to effectively radially expand and urge the filter sac into engagement with the vessel wall.




On the other hand, as shown in

FIGS. 1A and 1B

, the bending stresses imposed upon the hoop of such previously known devices, if drawn within a delivery catheter, may be sufficiently high to result in the formation of kink


18


at the tip of the hoop. This “kinking” effect becomes more severe in sheaths having a small inner diameter. Thus, for example, applicant has observed that when sheaths having inner diameters of 0.035″ or smaller are used, a hoop of nitinol or multi-strand nitinol cable having a diameter of 0.0055″ will form kink


18


. Kink


18


in turn may apply relatively high localized pressure and friction against wall


17


of sheath


16


, thereby making the vascular filter difficult to deploy. In particular, the kink may impale wall


17


of delivery sheath


16


and may make it difficult or impossible to deploy the vascular filter, especially in tortuous anatomy.




In addition, when the filter is subsequently deployed in vessel V, as shown in

FIG. 1B

, kink


18


may deform the pre-formed shape of hoop


12


, impairing the ability of the filter to seal against the walls of vessel V. This may in turn lead to the presence of gaps G between the perimeter of the hoop and the vessel wall, depending upon the severity of the kink. Consequently, emboli may pass through the gaps with antegrade flow and significantly reduce the efficacy of the filter. Additionally, kink


18


may be sufficiently sharp to damage or dissect the wall of vessel V when the filter is deployed.




The vascular device of the present invention solves the above-described disadvantages, providing a vascular device, suitable for use as a vascular filter in, for example, the ascending aorta, with a self-expanding support hoop that is sufficiently thick to radially expand and urge a blood permeable sac into engagement with the vessel wall, but which includes an articulation region that overcomes the problems associated with kinking. In particular, the vascular device of the present invention includes a reduced thickness articulation region and a pre-formed curved profile that avoids the difficulties of previously known systems while providing a high degree of efficacy in capturing emboli or thrombus, and ease of deployment and retrieval.




Referring now to

FIGS. 2A and 2B

, vascular device


20


constructed in accordance with the principles of the present invention, illustratively an embolic filter, comprises guide wire


22


, support hoop


24


having articulation region


26


, and blood permeable sac


28


affixed to support hoop


24


. Sac


28


is coupled to support hoop


24


so that the support hoop forms an opening for the sac. Support hoop


24


preferably is connected to guide wire


22


near distal end


23


of the guide wire.




Sac


28


preferably is constructed of a thin, flexible biocompatible material, such as polyethylene, polypropylene, polyurethane, polyester, polyethylene tetraphlalate, nylon or polytetrafluoroethylene, or combinations thereof, and includes openings or pores


30


that permit blood cells to pass through the sac substantially unhindered, while capturing any larger emboli that may be released during a procedure such as angioplasty or stent placement. In a preferred embodiment, sac


28


has openings or pores


30


in a range of about 20 to 400 microns in diameter, and more preferably, about approximately 80 microns. These pore sizes will permit red blood cells (which have a diameter of approximately 5 microns) to easily pass through the sac. If sac


28


comprises a woven material, such as formed from the above-mentioned polymers, the pore size of the sac may be determined as a function of the pattern and tightness of the weave.




Support hoop


24


comprises a hoop having a circular or rectangular cross-section that is formed of a super-elastic material, such as a nickel-titanium alloy (“nitinol”). During deployment and retrieval of vascular device


20


, described hereinafter, support hoop


24


folds in half and collapses to fit within a small diameter delivery sheath. When vascular device


20


is in a deployed state, as depicted in

FIG. 2A

, support hoop


24


resumes its pre-formed shape. Support hoop


24


preferably comprises nitinol wire, although it may also be formed from a multistrand nitinol cable, or other super-elastic material.




In accordance with the principles of the present invention, support hoop


24


includes one or more reduced-thickness articulation regions


26


and curved regions


34


. As depicted in

FIG. 2B

, articulation region


26


includes a region having reduced thickness t


1


compared to thickness t of the remainder of support hoop


24


. Articulation region


26


and curved regions


34


enable support hoop


24


to fold with a pre-determined shape when vascular device


20


is collapsed to a contracted state for delivery or retrieval.




In

FIG. 2B

, articulation region


26


is depicted as a localized reduction in the thickness of support hoop


24


, as may be achieved using conventional grinding or etching processes. Alternatively, support hoop


24


may be continuously tapered along its circumference, so that articulation region


26


results from a more gradual reduction in the wall thickness of the support hoop. Tapering support hoop


24


may permit greater flexibility in the vicinity of articulation region


26


, thus enabling support hoop


24


to fold more easily at the articulation region. Such tapering of the thickness of the support hoop along a portion of its circumference also may reduce the potential for stress-induced fracture typically associated with abrupt changes in diameter.




In a preferred embodiment of the vascular device


20


of the present invention, vascular device


20


easily fits within a delivery sheath having an inner diameter of 0.033″, and more preferably, may be used with a delivery sheath having an inner diameter as small as 0.026″. The deployed diameter of support hoop


24


preferably is approximately 7 mm, while guide wire


22


preferably has a diameter of 0.014″, and tapers at its distal end. The distal end of guide wire


22


also may be tipped with a spring section, or coil tip (not shown).




Support hoop


24


preferably is constructed of 0.0055″ nitinol wire tapered (by a grinding process) to 0.0025″ at articulation region


26


. Specifically, articulation region


26


preferably consists of a length about 0.05″ long and having a diameter of 0.0025″, coupled on either side to curved regions


34


. Each of curved regions


34


includes of a length of wire that is tapered from a diameter of 0.055″ to a diameter of 0.0025″ over a length of about 0.025″. Support hoop


24


also may include radiopaque features, such as gold or platinum bands


33


, spaced at intervals around the circumference of support hoop


24


, or a coil of radiopaque material wrapped around the support member.




With respect to

FIGS. 3 and 4

, additional features of vascular device


20


are described.

FIG. 3

depicts vascular device


20


of

FIG. 2A

in a contracted state, while

FIG. 4

illustrates a directional change in support hoop


24


preferably caused by the presence of curved regions


34


. In the embodiment depicted in FIG.


4


, curved regions


34


illustratively are configured to orient articulation region


26


in a direction parallel to the axis of guide wire


22


.




Advantageously, use of articulation region


26


and the curved profile of support hoop


24


introduced by curved regions


34


also cause support hoop


24


to fold in half during retrieval. As shown in

FIG. 3

, support hoop


24


folds in half, effectively closing the mouth of blood permeable sac


28


and preventing the escape of collected emboli or thrombus. This feature also may permit the use of a smaller or shallower sac than would otherwise be possible, without increasing the risk of material escaping from the device when the sac is collapsed for retrieval. Use of a smaller or shallower sac also enables vascular device


20


to be delivered in a smaller delivery sheath, having an inner diameter as small as 0.026″ for the preferred embodiment.




Referring now to

FIGS. 5A and 5B

, an embodiment of the vascular device of the present invention suited for use as a vascular filter in the ascending aorta is described. Vascular device


50


comprises guide wire


51


having distal end


52


with stop restraint


53


, which may be radiopaque. Elongated member


54


is rigidly attached to linear bearing


55


, which is slidably attached to guide wire


51


. Elongated member


54


therefore may be advanced over guide wire


51


to contact internal face


62


of delivery sheath


61


, and advance the delivery sheath. Delivery sheath


61


comprises tapered end


63


having lumen


64


through which guide wire


51


passes, and preferably also comprises radiopaque band


65


. Distally-facing support hoop


56


has blood permeable sac


57


attached to its perimeter. Support hoop


56


is, in turn, connected to elongated member


54


at attachment point


58


. Articulation region


59


and curved regions


60


of support hoop


56


enable the sides of the support hoop to fold together and become elongated when urged within cavity


66


of delivery sheath


61


by distal motion of elongated member


54


with guide wire


51


held stationary, or vice versa.




With reference to

FIGS. 6A-6C

, a method of deploying, using and retrieving vascular device


50


of

FIGS. 5

in the ascending aorta is described. In

FIG. 6A

, guide wire


51


is manipulated into position within ascending aorta AA just proximal of aortic valve AV using well-known percutaneous techniques, for example, based on the position of radiopaque restraint


53


under a fluoroscope. Vascular device


50


is disposed in its contracted state within delivery sheath


61


. The proximal end of guide wire


51


is passed through lumen


64


of sheath


61


and through linear bearing


55


, which is rigidly attached to elongated member


54


. Elongated member


54


with attached support hoop


56


and blood permeable sac


57


then is slidably advanced over guide wire


51


. In particular, linear bearing


55


contacts internal face


62


of sheath


61


and advances delivery sheath


61


and vascular device


50


.




Vascular device


50


is advanced until it contacts restraint


53


at distal end


52


of guide wire


51


. Restraint


53


prevents further distal motion of sheath


61


with respect to guide wire


51


. The location of vascular device


50


may be verified using, for example, the position of radiopaque band


65


under a fluoroscope, so that vascular device


50


lies within ascending aorta AA proximal of aortic valve AV, but distal of brachiocephalic trunk BT.




Referring now to

FIG. 6B

, with vascular device


50


in position, elongated member


54


is retracted proximally while guide wire


51


and sheath


61


are held stationary. Alternatively, elongated member


54


may be held stationary while guide wire


51


and delivery sheath


61


are advanced (in this case, distal end


52


of guide wire


51


is not initially advanced as far and lies just proximal of aortic valve AV only after deployment of vascular device


50


). In either case, when vascular device


50


is no longer confined within delivery sheath


61


, support hoop


56


expands to seal against the walls of the ascending aorta AA. Blood continues to flow unimpeded through ascending aorta AA in direction D. Emboli generated upstream (distal) of vascular device


50


by, for example, interventional instruments, such as angioplasty catheters, atherectomy devices, or stent delivery systems, are captured within sac


57


.




With respect to

FIG. 6C

, once the interventional procedure is complete and generated emboli have been captured within sac


57


, elongated member


54


is advanced distally while guide wire


51


and delivery sheath


61


are held stationary. The sides of support hoop


56


collapse together to close the mouth of sac


57


(see FIG.


3


). Additional distal advancement of member


54


urges support hoop


56


and sac


57


at least partially within cavity


66


of sheath


61


. As depicted in

FIG. 6C

, only a portion of support hoop


56


near articulation region


59


and a distal portion of sac


57


extend out of delivery sheath


61


. Guide wire


51


is then retracted proximally. Restraint


53


contacts the distal face of sheath


61


, which in turn contacts bearing


55


at internal face


62


and causes the whole of vascular device


50


with any trapped emboli to be withdrawn proximally.




As will of course be understood by those of skill in the art of catheter design,

FIGS. 5 and 6

have not been drawn to scale to clarify certain aspects of the structure of the preferred embodiments. For example, the diameter of delivery sheath


61


is approximately an order of magnitude smaller than either the inner diameter of the ascending aorta or the full deployed height of support hoop


57


.




Although preferred illustrative embodiments of the present invention are described above, it will be evident to one skilled in the art that various changes and modifications may be made without departing from the invention. It is intended in the appended claims to cover all such changes and modifications that fall within the true spirit and scope of the invention.



Claims
  • 1. Apparatus suitable for filtering emboli comprising:an elongated member having a distal region; a support hoop attached to the distal region, the support hoop having an articulation region; and a blood permeable sac affixed to the support hoop so that the support hoop forms a distally-facing mouth of the blood permeable sac; a guide wire slidably attached to the elongated member; and a delivery sheath having a proximally-facing cavity for accepting the elongated member, support hoop and blood permeable sac, and a lumen extending through the cavity to permit the guide wire to pass therethrough.
  • 2. The apparatus of claim 1, wherein the blood permeable sac comprises a biocompatible material.
  • 3. The apparatus of claim 2, wherein the biocompatible material comprises a material chosen from a list consisting of polyethylene, polypropylene, polyester, polyurethane and nylon.
  • 4. The apparatus of claim 3, wherein the blood permeable sac comprises a plurality of pores, each one of the plurality of pores having a diameter in a range of 20 to 400 microns.
  • 5. The apparatus of claim 1, wherein the support hoop comprises a super-elastic material.
  • 6. The apparatus of claim 1, wherein the support hoop comprises a wire having a thickness that tapers to a minimum thickness at the articulation region.
  • 7. The apparatus of claim 1 wherein the elongated member abuts against an interior surface of the cavity so that distal translation of the elongated member is transmitted to the delivery sheath.
  • 8. The apparatus of claim 1, wherein the apparatus has a deployed state, wherein the support hoop engages an interior wall of a patient's vessel, and a delivery state, wherein the apparatus has a contracted configuration to permit insertion of the elongated member, support hoop, and blood permeable sac within the delivery sheath.
  • 9. The apparatus of claim 8, wherein the support hoop folds at the articulation region when the apparatus is contracted to the delivery state.
  • 10. The apparatus of claim 8, wherein the mouth of the blood permeable sac is closed when the apparatus is in the contracted configuration, thereby preventing emboli from escaping from the blood permeable sac.
  • 11. The apparatus of claim 10 wherein opposite sides of the support hoop close towards one another when the apparatus is contracted to its contracted configuration.
  • 12. The apparatus of claim 1, wherein the delivery sheath further comprises a radiopaque band.
  • 13. The apparatus of claim 1, wherein the support hoop further comprises a radiopaque band.
  • 14. A method of trapping emboli or thrombus during a medical procedure, the method comprising:providing apparatus comprising an elongated member, a support hoop having an articulation region coupled to the elongated member, a blood permeable sac affixed to the support hoop so that the support hoop forms a distally-facing mouth of the blood permeable sac, a guide wire slidably attached to the elongated member having a distal region with a stop, and a delivery sheath having a cavity for accepting the elongated member, support hoop and blood permeable sac; advancing the guide wire to a desired location within a patient's vessel; positioning the elongated member, support hoop, and blood permeable sac in a contracted delivery state within the delivery sheath; advancing the elongated member and delivery sheath over the guide wire until the delivery sheath contacts the stop; and with the guide wire held stationary, withdrawing the elongated member to withdraw the support hoop from the cavity so that the apparatus expands to a deployed state wherein the support hoop seals against the vessel wall.
  • 15. The method of claim 14 further comprising:performing the medical procedure, the apparatus catching emboli released when the medical procedure is performed; advancing the elongated member over the guide wire to return the apparatus to a collapsed configuration within the cavity of the delivery sheath; and removing the apparatus from the patient's vessel.
  • 16. The method of claim 14, wherein advancing the elongated member and delivery sheath further comprises advancing the elongated member and delivery sheath to a location within the patient's ascending aorta proximal of the aortic valve, so that the apparatus is distal of the brachiocephalic trunk in the deployed state.
  • 17. The method of claim 14 wherein advancing the elongated member and delivery sheath further comprises advancing the elongated member and delivery sheath against a direction of blood flow through the patient's vessel.
  • 18. The method of claim 15, wherein returning the apparatus to a collapsed configuration within the delivery sheath channel comprises folding the support hoop at the articulation region to close the mouth of the blood permeable sac.
  • 19. Apparatus suitable for filtering emboli comprising:an elongated member having a distal region; a support hoop attached to the distal region, the support hoop having an articulation region; a blood permeable sac affixed to the support hoop so that the support hoop forms a distally-facing mouth of the blood permeable sac; a guide wire slidably attached to the elongated member; and a delivery sheath having a proximally-facing cavity for accepting the elongated member, support hoop and blood permeable sac.
  • 20. The apparatus of claim 19 further comprising a lumen extending through the cavity to permit the guide wire to pass therethrough.
REFERENCE TO RELATED APPLICATIONS

This application is a continuation-in-part of U.S. patent application Ser. No. 09/364,064 filed Jul. 30, 1999.

US Referenced Citations (191)
Number Name Date Kind
3472230 Fogarty Oct 1969 A
3592186 Oster Jul 1971 A
3683904 Forster Aug 1972 A
3889657 Baumgarten Jun 1975 A
3952747 Kimmell, Jr. Apr 1976 A
3996938 Clark, III Dec 1976 A
4046150 Schwartz et al. Sep 1977 A
4425908 Simon Jan 1984 A
4447227 Kotsanis May 1984 A
4580568 Gianturco Apr 1986 A
4590938 Segura et al. May 1986 A
4619246 Molgaard-Nielsen et al. Oct 1986 A
4631052 Kensey Dec 1986 A
4643184 Mobin-Uddin Feb 1987 A
4650446 Luther Mar 1987 A
4662885 DiPisa, Jr. May 1987 A
4705517 DiPisa, Jr. Nov 1987 A
4706671 Weinrib Nov 1987 A
4723549 Wholey et al. Feb 1988 A
4728319 Masch Mar 1988 A
4733665 Palmaz Mar 1988 A
4784928 Kletschka Nov 1988 A
4790812 Hawkins, Jr. et al. Dec 1988 A
4790813 Kensey Dec 1988 A
4794928 Kletschka Jan 1989 A
4794931 Yock Jan 1989 A
4800882 Gianturco Jan 1989 A
4807626 McGirr Feb 1989 A
4842579 Shiber Jun 1989 A
4857045 Rydell Aug 1989 A
4857046 Stevens et al. Aug 1989 A
4867157 McGurk-Burleson et al. Sep 1989 A
4873978 Ginsburg Oct 1989 A
4898575 Fischell et al. Feb 1990 A
4907336 Gianturco Mar 1990 A
4921478 Solano et al. May 1990 A
4921484 Hillstead May 1990 A
4926858 Gifford et al. May 1990 A
4950277 Farr Aug 1990 A
4955895 Sugiyama et al. Sep 1990 A
4957482 Shiber Sep 1990 A
4969891 Gewertz Nov 1990 A
4979951 Simpson Dec 1990 A
4986807 Farr Jan 1991 A
4998539 Delsanti Mar 1991 A
5002560 Machold et al. Mar 1991 A
RE33569 Gifford, III et al. Apr 1991 E
5007896 Shiber Apr 1991 A
5007917 Evans Apr 1991 A
5011488 Ginsburg Apr 1991 A
5019088 Farr May 1991 A
5041126 Gianturco Aug 1991 A
5053008 Bajaj Oct 1991 A
5053044 Mueller et al. Oct 1991 A
5071407 Termin et al. Dec 1991 A
5071425 Gifford, III et al. Dec 1991 A
5085662 Willard Feb 1992 A
5087265 Summers Feb 1992 A
5100423 Fearnot Mar 1992 A
5100424 Jang et al. Mar 1992 A
5100425 Fischell et al. Mar 1992 A
5102415 Guenther et al. Apr 1992 A
5104399 Lazarus Apr 1992 A
5108419 Reger et al. Apr 1992 A
5133733 Rasmussen et al. Jul 1992 A
5135531 Shiber Aug 1992 A
5152771 Sabbaghian et al. Oct 1992 A
5152777 Goldberg et al. Oct 1992 A
5160342 Reger et al. Nov 1992 A
5171233 Amplatz et al. Dec 1992 A
5190546 Jervis Mar 1993 A
5195955 Michael Mar 1993 A
5224953 Morgentaler Jul 1993 A
5306286 Stack et al. Apr 1994 A
5314444 Gianturco May 1994 A
5314472 Fontaine May 1994 A
5318576 Plassche, Jr. et al. Jun 1994 A
5329942 Gunther et al. Jul 1994 A
5330484 Gunther Jul 1994 A
5330500 Song Jul 1994 A
5350398 Pavcnik et al. Sep 1994 A
5354310 Garnic et al. Oct 1994 A
5356423 Tihon et al. Oct 1994 A
5366464 Belknap Nov 1994 A
5366473 Winston et al. Nov 1994 A
5370657 Irie Dec 1994 A
5376100 Lefebvre Dec 1994 A
5383887 Nadal Jan 1995 A
5383892 Cardon et al. Jan 1995 A
5383926 Lock et al. Jan 1995 A
5387235 Chuter Feb 1995 A
5395349 Quiachon et al. Mar 1995 A
5397345 Lazerus Mar 1995 A
5405377 Cragg Apr 1995 A
5409454 Fischell et al. Apr 1995 A
5415630 Gory et al. May 1995 A
5419774 Willard et al. May 1995 A
5421832 Lefebvre Jun 1995 A
5423742 Theron Jun 1995 A
5423885 Williams Jun 1995 A
5425765 Tiefenbrun et al. Jun 1995 A
5443498 Fontaine Aug 1995 A
5449372 Schmaltz et al. Sep 1995 A
5456667 Ham et al. Oct 1995 A
5462529 Simpson et al. Oct 1995 A
5476104 Sheahon Dec 1995 A
5484418 Quiachon et al. Jan 1996 A
5507767 Maeda et al. Apr 1996 A
5512044 Duer Apr 1996 A
5527354 Fontaine et al. Jun 1996 A
5536242 Willard et al. Jul 1996 A
5540707 Ressemann et al. Jul 1996 A
5549626 Miller et al. Aug 1996 A
5562724 Vowerk et al. Oct 1996 A
5569274 Rapacki et al. Oct 1996 A
5569275 Kotula et al. Oct 1996 A
5634897 Dance et al Jun 1997 A
5658296 Bates et al. Aug 1997 A
5662671 Barbut et al. Sep 1997 A
5669933 Simon et al. Sep 1997 A
5695519 Summers et al. Dec 1997 A
5709704 Nott et al. Jan 1998 A
5720764 Naderlinger Feb 1998 A
5728066 Daneshvar Mar 1998 A
5746758 Nordgren et al. May 1998 A
5749848 Jang et al. May 1998 A
5769816 Barbut et al. Jun 1998 A
5779716 Cano et al. Jul 1998 A
5792300 Inderbitzen et al. Aug 1998 A
5795322 Boudewijn Aug 1998 A
5797952 Klein Aug 1998 A
5800457 Gelbfish Sep 1998 A
5800525 Bachinski et al. Sep 1998 A
5810874 Lefebvre Sep 1998 A
5814064 Daniel et al. Sep 1998 A
5817102 Johnson et al. Oct 1998 A
5827324 Cassell et al. Oct 1998 A
5833644 Zadno-Azizi et al. Nov 1998 A
5833650 Imran Nov 1998 A
5846260 Maahs Dec 1998 A
5848964 Samuels Dec 1998 A
5876367 Kaganov et al. Mar 1999 A
5893867 Bagaoisan et al. Apr 1999 A
5895399 Barbut et al. Apr 1999 A
5902263 Patterson et al. May 1999 A
5906618 Larson, III May 1999 A
5908435 Samuels Jun 1999 A
5910154 Tsugita et al. Jun 1999 A
5911734 Tsugita et al. Jun 1999 A
5916193 Stevens et al. Jun 1999 A
5925016 Chornenky et al. Jul 1999 A
5925060 Forber Jul 1999 A
5925062 Purdy Jul 1999 A
5925063 Khosravi Jul 1999 A
5928203 Davey et al. Jul 1999 A
5928218 Gelbfish Jul 1999 A
5934284 Plaia et al. Aug 1999 A
5935139 Bates Aug 1999 A
5938645 Gordon Aug 1999 A
5941869 Patterson et al. Aug 1999 A
5941896 Kerr Aug 1999 A
5947995 Samuels Sep 1999 A
5951585 Cathcart et al. Sep 1999 A
5954745 Gertler et al. Sep 1999 A
5976172 Homsma et al. Nov 1999 A
5989201 Morris et al. Nov 1999 A
5989271 Bonnette et al. Nov 1999 A
5989581 Barbut et al. Nov 1999 A
5993469 McKenzie et al. Nov 1999 A
5997557 Barbut et al. Dec 1999 A
6001118 Daniel et al. Dec 1999 A
6007557 Ambrisco et al. Dec 1999 A
6010522 Barbut et al. Jan 2000 A
6013085 Howard Jan 2000 A
6027520 Tsugita et al. Feb 2000 A
6051014 Jang Apr 2000 A
6053932 Daniel et al. Apr 2000 A
6059814 Ladd May 2000 A
6068645 Tu May 2000 A
6086605 Barbut et al. Jul 2000 A
6129739 Khosravi Oct 2000 A
6142987 Tsugita Nov 2000 A
6152946 Broome et al. Nov 2000 A
6165200 Tsugita et al. Dec 2000 A
6168579 Tsugita Jan 2001 B1
6171327 Daniel et al. Jan 2001 B1
6179851 Barbut et al. Jan 2001 B1
6179859 Bates et al. Jan 2001 B1
6179861 Khosravi et al. Jan 2001 B1
6203561 Ramee et al. Mar 2001 B1
6214026 Lepak et al. Apr 2001 B1
Foreign Referenced Citations (69)
Number Date Country
34 17 738 Nov 1985 DE
40 30 998 Oct 1990 DE
0 200 688 Nov 1986 EP
0 293 605 Dec 1988 EP
0 427 429 May 1991 EP
0 411 118 Jun 1991 EP
0 437 121 Jul 1991 EP
0 472 334 Feb 1992 EP
0 472 368 Feb 1992 EP
0 553 511 Mar 1993 EP
0 655 228 Nov 1994 EP
0 686 379 Jun 1995 EP
0 696 447 Feb 1996 EP
0 737 450 Oct 1996 EP
0 743 046 Nov 1996 EP
0 759 287 Feb 1997 EP
0 771 549 May 1997 EP
0 784 988 Jul 1997 EP
0 852 132 Jul 1998 EP
2 580 504 Oct 1986 FR
2 643 250 Aug 1990 FR
2 666 980 Mar 1992 FR
2 768 326 Mar 1999 FR
2 020 557 Nov 1979 GB
8-187294 Jul 1996 JP
764684 Sep 1980 SU
WO 9203097 Mar 1992 WO
WO 9414389 Jul 1994 WO
WO 9424946 Nov 1994 WO
WO 9601591 Jan 1996 WO
WO 9610375 Apr 1996 WO
WO 9619941 Jul 1996 WO
WO 9623441 Aug 1996 WO
WO 9333677 Oct 1996 WO
WO 9717100 May 1997 WO
WO 9727808 Aug 1997 WO
WO 9742879 Nov 1997 WO
WO 9802084 Jan 1998 WO
WO 9802112 Jan 1998 WO
WO 9823322 Jun 1998 WO
WO 9833443 Aug 1998 WO
WO 9834673 Aug 1998 WO
WO 9836786 Aug 1998 WO
WO 9838920 Sep 1998 WO
WO 9838929 Sep 1998 WO
WO 9839046 Sep 1998 WO
WO 9839053 Sep 1998 WO
WO 9846297 Oct 1998 WO
WO 9847447 Oct 1998 WO
WO 9849952 Nov 1998 WO
WO 9850103 Nov 1998 WO
WO 9851237 Nov 1998 WO
WO 9855175 Dec 1998 WO
WO 9909895 Mar 1999 WO
WO 9922673 May 1999 WO
WO 9923976 May 1999 WO
WO 9925252 May 1999 WO
WO 9930766 Jun 1999 WO
0 934 729 Aug 1999 WO
WO 9940964 Aug 1999 WO
WO 9942059 Aug 1999 WO
WO 9944510 Sep 1999 WO
WO 9944542 Sep 1999 WO
WO 9955236 Nov 1999 WO
WO 9958068 Nov 1999 WO
WO 0007655 Jan 2000 WO
WO 0009054 Feb 2000 WO
WO 0016705 Mar 2000 WO
WO 0049970 Aug 2000 WO
Non-Patent Literature Citations (21)
Entry
Wholey, Mark H. et al., “PTA and Stents in the Treatment of Extracranial Circulation,” The Journal of Invasive Cardiology: vol. 8/Supplement E, Health Management Publications, Inc., 1996, pp. 25E-30E.
Fadali, A. Moneim, “A filtering device for the prevention of particulate embolization during the course of cardiac surgery”, Surgery, vol. 64(3), pp. 634-639 (Sep. 1968).
“Atherosclerotic Disease of the Aortic Arch as a Risk Factor of Recurrent Ischemic Stroke,” The New England Journal of Medicine, pp. 1216-1221 (May 1996).
“Endovascular Grafts, Stents Drive International Radiology Growth, ” Cardiovascular Device Update, 2(3):1-12 (Mar. 1996).
“Protruding Atheromas in the Thoracic Aortic and Systemic Embolization,” pp. 423-427 American College of Physicians (1991).
“Recognition and Embolic Potential of Intraaortic Atherosclerotic Debris,” American College of Cardiology (Jan. 1991).
Cragg, Andrew et al., “A New Percutaneous Vena Cava Filger,” AJR, 141:601-604 (Sep. 1983).
Cragg, Andrew et al., “Nonsurgical Placement of Arterial Endoprosthesis: A New Technique Using Nitinol Wire,” AJR, pp. 261-263 (Apr. 1983).
Diethrich et al., “Percutaneous Techniques for Endoluminal Carotid Interventions,” J. Endovasc. Surg., 3:182-202 (1996).
Haissaguerra et al., “Spontaneous Initiation of Atrial Fibrillation by Ectopic Beats Originating in the Pulmonary Veins,” The New England Journal of Medicine, 339(10):659-666 (Sep. 1988).
Jordan, Jr. et al., “Microemboli Detected by Transcranial Doppler Monitoring...,” Cardiovascular Surgery, 7(1)33-38 (Jan. 1999).
Lesh, “Can Catheter Ablation Cure Atrial Fibrillation?” ACC Current Journal Review, pp. 38-40 Sep./Oct. 1997).
Lund et al., “Long-Term Patentcy of Ductus Arteriosus After Balloon Dilation: an Experimental Study,” Laboratory Investigation, 69(4):772-774 (Apr. 1984).
Marache et al., “Percutaneous Transluminal Venous Angioplasty...,” America Heart Journal, 125(2 Pt 1):362 -366 (Feb. 1993).
Mazur et al., “Directional Atherectomy with the Omnicath198 : A Unique New Catheter System, ”Catheterization and Cardiovascular Diagnosis, 31:17-84 (1994).
Moussa, MD, Issaam “Stents Don't Require Systemic Anticoagulation...But the Technique (and Results) Must be Optimal,”Journal of Invasive Cardiol., 8(E):3E-7E, (1996).
Nakanishi et al., “Catheter Intervention to Venous System Using Expandable Metallic Stents,” Rinsho Kyobu Geka, 14(2):English Abstract Only (Apr. 1994).
Onal et al., “Primary Stenting for Complex Atherosclerotic Plaques in Aortic and Iliac Stenoses,” Cardiovascular & Interventional Radiology, 21(5):386-392 (1998).
Theron et al., “New Triple Coaxial Catheter System for Carotid Angioplasty with Cerebral Protection,” American Journal of Neuroradiology, 11:869-874 (1990).
Tunick et al., “Protruding atherosclerotic plaque in the aortic archo f patients with systemic embolization: A new finding seen by transesophageal echocardiography,” American Heart Journal 120(3):658-660 (Sep. 1990).
Waksman et al., “Distal Embolization is Common After Directional Atherectomy...,” American Heart Journal, 129(3):430-435 (1995).
Continuation in Parts (1)
Number Date Country
Parent 09/364064 Jul 1999 US
Child 09/470706 US